| |
| |
|
| Insider
Information: |
Coughlin Christopher J |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
342,599 |
|
|
Indirect Shares
|
17,342 |
|
|
| Direct
Value |
$12,307,323 |
|
|
|
Indirect Value
|
$3,201,457 |
|
|
| Total
Shares |
359,941 |
|
|
| Total
Value |
$15,508,780 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -5.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpublic Group of Companies |
IPG |
CFO and COO, Director |
2004-05-18 |
81,842 |
2004-05-18 |
0 |
Premium* |
|
|
Dun & Bradstreet Corp |
DNB |
Director |
2017-03-10 |
16,535 |
2017-03-10 |
800 |
Premium* |
|
|
Johnson Controls International plc |
JCI |
EVP and CFO |
2010-11-26 |
88,558 |
2005-03-07 |
0 |
Premium* |
|
|
Covidien Plc |
COV |
Director |
2015-01-26 |
0 |
2015-01-26 |
0 |
Premium* |
|
|
Plx Pharma Inc |
PLXP |
Director |
2014-03-18 |
109,309 |
|
0 |
Premium* |
|
|
Allergan plc |
AGN |
Director |
2020-05-08 |
0 |
2020-05-08 |
16,542 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2021-07-21 |
0 |
2014-07-22 |
0 |
Premium* |
|
|
Hologic Inc |
HOLX |
Director |
2017-03-08 |
7,633 |
|
0 |
Premium* |
|
|
Prestige Brands Holdings Inc |
PBH |
Director |
2022-08-02 |
13,218 |
2019-07-30 |
0 |
Premium* |
|
|
Centene Corp |
CNC |
Director |
2024-05-14 |
25,504 |
2022-02-07 |
0 |
Premium* |
|
|
Karuna Therapeutics, Inc. |
KRTX |
|
2024-03-18 |
0 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRTX |
Karuna Therapeutics, Inc. |
|
• • – |
2024-03-18 |
4 |
D |
$330.00 |
$326,700 |
D/D |
(990) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2020-05-01 |
4 |
D |
$189.74 |
$188,032 |
D/D |
(991) |
16,542 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
• • – |
2014-03-19 |
4 |
D |
$70.68 |
$73,931 |
D/D |
(1,046) |
49,016 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2011-03-15 |
4 |
D |
$51.09 |
$53,542 |
D/D |
(1,048) |
45,617 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2016-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,087 |
16,281 |
0 |
- |
|
| CNC |
Centene Corp |
Director |
– • – |
2022-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,100 |
1,100 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2014-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,141 |
13,780 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2016-05-05 |
4 |
A |
$210.34 |
$249,884 |
D/D |
1,188 |
3,790 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2017-05-04 |
4 |
A |
$245.25 |
$299,941 |
D/D |
1,223 |
4,446 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2011-03-15 |
4 |
D |
$51.09 |
$63,045 |
D/D |
(1,234) |
44,383 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2011-02-09 |
4 |
A |
$84.70 |
$120,020 |
D/D |
1,417 |
9,047 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2013-02-19 |
4 |
A |
$82.56 |
$119,952 |
D/D |
1,453 |
12,390 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2009-02-04 |
4 |
A |
$79.58 |
$119,927 |
D/D |
1,507 |
5,698 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2012-02-13 |
4 |
A |
$79.11 |
$120,002 |
D/D |
1,517 |
10,737 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2014-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,640 |
1,640 |
0 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2010-02-11 |
4 |
A |
$70.54 |
$119,989 |
D/D |
1,701 |
7,494 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2018-05-02 |
4 |
A |
$151.07 |
$299,874 |
D/D |
1,985 |
6,431 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-06-15 |
4 |
B |
$117.10 |
$234,200 |
D/D |
2,000 |
6,333 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,333 |
0 |
- |
|
| AGN |
Allergan plc |
Director |
– • – |
2019-05-02 |
4 |
A |
$145.33 |
$299,961 |
D/D |
2,064 |
17,080 |
0 |
- |
|
| PLXP |
Plx Pharma Inc |
Director |
– • – |
2014-03-18 |
4 |
B |
$12.00 |
$24,996 |
D/D |
2,083 |
109,309 |
2.39 |
- |
|
| DNB |
Dun & Bradstreet Corp |
Director |
– • – |
2017-01-26 |
4 |
OE |
$88.04 |
$183,651 |
D/D |
2,086 |
18,547 |
0 |
- |
|
| COV |
Covidien Plc |
Director |
– • – |
2007-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,090 |
63,507 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,174 |
28,507 |
0 |
- |
|
| HOLX |
Hologic Inc |
Director |
• • – |
2017-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,206 |
7,633 |
0 |
- |
|
180 Records found
|
|
Page 5 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
